Business Context and Reporting Period
Park Ha Biological Technology Co., Ltd. filed Form 6-K on October 8, 2025, reporting on the 2025 Annual General Meeting held on October 3, 2025. The Company is a foreign private issuer headquartered in Wuxi, Jiangsu Province, China.
Key Financial Metrics
This filing is a report of shareholder voting results and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Corporate Actions
Shareholders approved several significant corporate governance and capital structure changes:
- Dual-Class Share Structure: The Company approved a re-designation of shares into 12 billion Class A ordinary shares (1 vote per share) and 3 billion Class B ordinary shares (20 votes per share). Existing shares were reclassified as Class A, and 19,050,000 Class A shares held by Xiaoqiu Zhang were surrendered for nil consideration and replaced with 19,050,000 Class B shares.
- Share Capital Increase: Authorized share capital was increased by US$250,000 to a total of US$300,000, divided into 15 billion ordinary shares with a par value of US$0.00002 each.
- Share Consolidation: Shareholders approved a share consolidation ratio ranging from 1-for-5 to 1-for-30. The exact ratio and effective date are to be determined by the Board of Directors.
- Charter Amendment: The Amended and Restated Memorandum and Articles of Association were approved to reflect the new dual-class structure and streamline shareholder meeting requirements.
- Auditor Ratification: WWC P.C. was ratified as the independent registered public accounting firm for the fiscal year ending October 31, 2025.
Voting Results Summary
| Matter | For | Against | Abstain |
|---|---|---|---|
| Re-designation and Re-classification of Shares | 21,655,675 | 213,990 | 3,088 |
| Amendment of Articles of Association | 21,653,388 | 216,112 | 3,253 |
| Share Consolidation | 21,684,731 | 184,942 | 3,080 |
| Ratification of Auditor | 21,707,846 | 161,651 | 3,256 |
Total shares voted: 21,872,753 out of 33,874,403 issued and outstanding.
Outlook, Risks, and Contingencies
The filing does not provide management commentary on financial outlook, specific risks, or contingencies. The primary contingency noted is the future determination of the exact share consolidation ratio and effective date by the Board of Directors.
Key Facts for Investor Verification
- Verify the exact share consolidation ratio (between 1-for-5 and 1-for-30) once announced by the Board.
- Confirm the effective date of the share consolidation and the dual-class structure implementation.
- Review the full text of the New Amended and Restated Memorandum and Articles of Association (Exhibit 3.1) for specific rights and restrictions of Class A and Class B shares.
- Note that the filing contains no financial performance data; refer to the Company's Form 20-F for fiscal results.